Theradiag

📍 Croissy Beaubourg, France🗓 Founded 1986👥 60 employees💰 Last funded Sep 2019
Biotechnology🌐 theradiag.com
Website LinkedIn
Capitalizing on its expertise in the distribution, development and manufacturing of in vitro diagnostic tests, Theradiag innovates and develops theranostics tests (combining treatment and diagnosis) that measure the efficiency of biotherapies in the treatment of autoimmune diseases and cancer. Theradiag is thus participating in the development of customized treatment, which favors the individualization of treatments, the evaluation of their efficacy and the prevention of drug resistance. Theradiag notably markets the Lisa Tracker® range (CE marked), which is a comprehensive multiparameter theranostic solution for patients with autoimmune diseases treated with biotherapies. The Company is based in Marne-la-Vallée, near Paris, and has over 65 employees.
3
Total investors
0
Early stage
0
Mid stage
0
Late stage
1986
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography3 countries
France
1
United Kingdom
1
Belgium
1
Investor activity2012–2019 · investors recorded per year
201212013120191
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Theradiag?
Theradiag has 3 investors on record on gritt.io.
When did Theradiag last raise funding?
The most recent investment in Theradiag recorded on gritt.io was in September 2019.
When was Theradiag founded?
Theradiag was founded in 1986.
What industry is Theradiag in?
Theradiag operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Theradiag based?
Theradiag is headquartered in Croissy Beaubourg, France.